IMATIB 100

Manufacturer
CIPLA
Packaging
Strip
Composition
IMATINIB MESYLATE TABLETS 100MG
Availability
OTC
SKU
PROD-00813

Product Description

🔹 Product Overview
Imatib 100 mg Tablet is a prescription anticancer medicine containing imatinib. It belongs to a class of targeted medicines known as tyrosine kinase inhibitors (TKIs). Imatib is used for specific cancers and blood disorders in which abnormal tyrosine kinase proteins contribute to uncontrolled cell growth. The product is marketed in India by Cipla Ltd.

🔹 Key Uses
Imatib 100 mg may be prescribed by a specialist for certain conditions, including:
Chronic myeloid leukemia (CML)
Certain forms of acute lymphoblastic/lymphocytic leukemia (ALL)
Gastrointestinal stromal tumors (GIST)
Dermatofibrosarcoma protuberans (DFSP)
Certain other rare conditions for which imatinib is specifically indicated
The exact indication depends on the patient's diagnosis and the molecular characteristics of the disease.

🔹 Composition
Active ingredient: Imatinib 100 mg, generally supplied as imatinib mesylate.
Therapeutic class: Antineoplastic agent / Tyrosine kinase inhibitor (TKI).
Imatinib works by selectively inhibiting certain abnormal tyrosine kinase proteins involved in cancer-cell growth.

🔹 How It Works
Certain cancers are driven by abnormal proteins that continuously send signals telling cells to grow and multiply. Imatinib blocks specific tyrosine kinase enzymes, including BCR-ABL in Philadelphia chromosome-positive CML, thereby reducing abnormal cell proliferation and promoting the death of affected cells.
This targeted mechanism allows imatinib to act on particular molecular pathways rather than functioning as a conventional nonspecific chemotherapy medicine.

🔹 Key Benefits
Targeted therapy for specific cancers and blood disorders
Helps inhibit abnormal cancer-cell growth
Used as an important treatment option for eligible patients with CML
Used for certain gastrointestinal stromal tumors
May be prescribed for specific cases of DFSP and other approved indications
Available as an oral tablet for convenient administration
Treatment benefits vary according to the underlying disease, genetic characteristics, treatment regimen, and individual response.

🔹 Dosage and Administration
The appropriate dose of Imatib 100 mg is individualized by an oncologist or other qualified specialist according to the patient's diagnosis, age, body weight, treatment response, blood counts, liver function, and other medical factors.
Take Imatib exactly as prescribed.
It is generally taken with food and a large glass of water to reduce gastrointestinal irritation.
Swallow the tablet as directed rather than changing the dosage yourself.
Take it at approximately the same time each day when instructed.
Do not stop treatment or change the dose without consulting the treating doctor.
If a dose is missed, follow the instructions provided by the prescribing doctor rather than taking an extra dose.
Because dosing differs substantially between conditions, a specific dose should not be inferred simply from the 100 mg tablet strength.

🔹 Possible Side Effects
Commonly reported side effects may include:
Nausea
Vomiting
Diarrhea
Abdominal discomfort or pain
Muscle cramps
Musculoskeletal pain
Fatigue
Rash
Headache or dizziness
Swelling/edema
More serious problems can occur, including significant fluid retention, changes in blood-cell counts, liver problems, and other clinically important reactions. Rapid unexplained weight gain, significant swelling, breathing difficulty, unusual bleeding, or severe weakness should be reported promptly to a healthcare professional.

🔹 Precautions and Warnings
Imatib should be used only under specialist medical supervision.
Regular blood tests may be required to monitor blood counts and liver function.
Tell your doctor if you have liver, kidney, heart, or thyroid problems.
Report unusual bleeding, severe swelling, shortness of breath, or rapid weight gain.
Imatinib can cause fetal harm; patients who are pregnant, planning pregnancy, or capable of becoming pregnant should discuss appropriate precautions with their doctor.
Breastfeeding may not be recommended during treatment; follow your specialist's advice.
Tell your doctor about all prescription medicines, OTC medicines, vitamins, and herbal products because imatinib can interact with other medicines.
Grapefruit and grapefruit juice may interact with imatinib and should be discussed with your healthcare professional.

Additional Information

  • Category: category change
  • Manufacturer: CIPLA
  • Packaging: Strip
  • Composition: IMATINIB MESYLATE TABLETS 100MG
  • Storage: Store in a cool, dry place away from direct sunlight
  • Shelf Life: As per manufacturer's guidelines
  • Prescription Status: Over-the-Counter (OTC)

How to Use

Important: Always follow your healthcare provider's instructions when using this medication.

  • Take this medicine as directed by your physician
  • Do not exceed the recommended dosage
  • Complete the full course of treatment even if symptoms improve
  • Store the medication properly as per storage instructions
  • Keep out of reach of children
  • Check expiry date before use

Note: This is general guidance. For specific instructions, please consult your healthcare provider or refer to the package insert.